Medications
Hepatitis C drug can cause depression
There's a high rate of depression among patients with hepatitis C, but a standard treatment for the disease includes a drug, interferon, that can cause depression.
May 1, 2012
0
0
News tagged with pegylated interferon
Diseases, Conditions, Syndromes
Drug interactions won't exclude HCV transplant or HIV co-infected patients from treatment
New data from a number of clinical trials presented for the first time at the International Liver Congress 2012 provides hope for previously difficult to treat hepatitis C (HCV) patient populations.
Apr 19, 2012
0
0
Diseases, Conditions, Syndromes
Hypoferremia predicts treatment response to IFN-α
(HealthDay) -- For patients with hepatitis C virus (HCV), hepcidin, a regulator of iron homeostasis, is induced following a single dose of pegylated interferon-α (PEG-IFNα), and may be a surrogate marker of immediate ...
Mar 1, 2012
0
0
Diseases, Conditions, Syndromes
Hepatitis C kills more Americans than HIV: study
More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS, US health authorities said this week.
Feb 23, 2012
0
0
Diseases, Conditions, Syndromes
P7 protein resistance mutations identified; represent drug targets for hepatitis C virus
British researchers have identified specific resistance mutations for two classes of p7 inhibitor, which may explain their lack of effectiveness in clinical trials combined with current standard of care. Study results support ...
Jun 28, 2011
0
0
Diseases, Conditions, Syndromes
Will new drugs block hepatitis C virus in its tracks?
Targeted multi-drug treatments for hepatitis C patients that could stop the virus in its tracks have come a step closer, thanks to researchers at the University of Leeds, UK.
Jun 28, 2011
0
0
Diseases, Conditions, Syndromes
Arrival of direct antiviral agent therapy for hepatitis C sparks debate of who to treat first
For many patients with the hepatitis C virus (HCV), direct antiviral agents (DAA) offer a potential cure for the disease. The Food and Drug Administration (FDA) has recently approved two new DAAs, telaprevir and boceprevir, ...
May 25, 2011
1
0
